RACIONALNA PRIMJENA SERUMSKIH TUMORSKIH BILJEGA U DIJAGNOSTICI I LIJEČENJU SOLIDNIH TUMORA (CROSBI ID 285225)
Prilog u časopisu | ostalo | međunarodna recenzija
Podaci o odgovornosti
Dedić Plavetić, Natalija ; Gnjidić, Milena ; Kulić, Ana ; Ivić, Marija ; Kukec, Ivana ; Vidović, Marina
hrvatski
RACIONALNA PRIMJENA SERUMSKIH TUMORSKIH BILJEGA U DIJAGNOSTICI I LIJEČENJU SOLIDNIH TUMORA
Optimal management of patients with solid tumors, depending on the tumour type, includes measurement of serum tumour markers levels. Serum tumour markers are heterogeneous molecules with concentrations elevated in persons with solid tumours, but could also be found in small amounts in plasma of healthy individuals. Elevated plasma concentrations are caused by cell changes, necrosis, changed expression or secretion of different molecules. In some tumour types tumour cells by themselves could stimulate other cells to secrete particular molecules
Tumorski biljezi – analiza, u krvi ; Tumori – dijagnoza ; Tumori prostate – dijagnoza ; Prostata specifični antigen – u krvi ; ...
nije evidentirano
engleski
RACIONALNA PRIMJENA SERUMSKIH TUMORSKIH BILJEGA U DIJAGNOSTICI I LIJEČENJU SOLIDNIH TUMORA
nije evidentirano
Tumorski biljezi – analiza, u krvi ; Tumori – dijagnoza ; Tumori prostate – dijagnoza ; Prostata specifični antigen – u krvi ; ...
nije evidentirano
Podaci o izdanju
138 (3-4)
2016.
85-92
objavljeno
0024-3477